Roberto Pili

  • 10771 Citations
  • 51 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1990 2019

73 Citations (Scopus)

Consensus guidelines for the use and interpretation of angiogenesis assays

Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., Bergers, G., Bikfalvi, A., Bischoff, J., Böck, B. C., Brooks, P. C., Bussolino, F., Cakir, B., Carmeliet, P., Castranova, D., Cimpean, A. M. & 66 others, Cleaver, O., Coukos, G., Davis, G. E., De Palma, M., Dimberg, A., Dings, R. P. M., Djonov, V., Dudley, A. C., Dufton, N. P., Fendt, S. M., Ferrara, N., Fruttiger, M., Fukumura, D., Ghesquière, B., Gong, Y., Griffin, R. J., Harris, A. L., Hughes, C. C. W., Hultgren, N. W., Iruela-Arispe, M. L., Irving, M., Jain, R. K., Kalluri, R., Kalucka, J., Kerbel, R. S., Kitajewski, J., Klaassen, I., Kleinmann, H. K., Koolwijk, P., Kuczynski, E., Kwak, B. R., Marien, K., Melero-Martin, J. M., Munn, L. L., Nicosia, R. F., Noel, A., Nurro, J., Olsson, A. K., Petrova, T. V., Pietras, K., Pili, R., Pollard, J. W., Post, M. J., Quax, P. H. A., Rabinovich, G. A., Raica, M., Randi, A. M., Ribatti, D., Ruegg, C., Schlingemann, R. O., Schulte-Merker, S., Smith, L. E. H., Song, J. W., Stacker, S. A., Stalin, J., Stratman, A. N., Van de Velde, M., van Hinsbergh, V. W. M., Vermeulen, P. B., Waltenberger, J., Weinstein, B. M., Xin, H., Yetkin-Arik, B., Yla-Herttuala, S., Yoder, M. & Griffioen, A. W., Aug 1 2018, In : Angiogenesis. 21, 3, p. 425-532 108 p.

Research output: Contribution to journalReview article

Bioassay
Biological Assay
Assays
Guidelines
Blood vessels
39 Citations (Scopus)

Contrasting effects of sunitinib within in vivo models of metastasis

Welti, J. C., Powles, T., Foo, S., Gourlaouen, M., Preece, N., Foster, J., Frentzas, S., Bird, D., Sharpe, K., Weverwijk, A. V., Robertson, D., Soffe, J., Erler, J. T., Pili, R., Springer, C. J., Mather, S. J. & Reynolds, A. R., 2012, In : Angiogenesis. 15, 4, p. 623-641 19 p.

Research output: Contribution to journalArticle

Tumors
Neoplasm Metastasis
Neoplasms
Lung
Cells
18 Citations (Scopus)

Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer

Ciamporcero, E., Daga, M., Pizzimenti, S., Roetto, A., Dianzani, C., Compagnone, A., Palmieri, A., Ullio, C., Cangemi, L., Pili, R. & Barrera, G., Feb 1 2018, In : Free Radical Biology and Medicine. 115, p. 447-457 11 p.

Research output: Contribution to journalArticle

Crosstalk
Urinary Bladder Neoplasms
Antioxidants
Cells
Transcription Factors
3 Citations (Scopus)

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer

Ramakrishnan, S., Hu, Q., Krishnan, N., Wang, D., Smit, E., Granger, V., Rak, M., Attwood, K., Johnson, C., Morrison, C., Pili, R., Chatta, G., Guru, K., Gueron, G., McNally, L., Wang, J. & Woloszynska-Read, A., Dec 1 2017, In : Cell Death and Disease. 8, 12, 3217.

Research output: Contribution to journalArticle

decitabine
Urinary Bladder Neoplasms
Interleukin-6
Muscles
DNA
9 Citations (Scopus)

Development of a castrate resistant transplant tumor model of prostate cancer

Ellis, L., Lehet, K., Ramakrishnan, S., Adelaiye, R. & Pili, R., May 1 2012, In : Prostate. 72, 6, p. 587-591 5 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Transplants
Neoplasms
Androgens
Androgen Receptors
2 Citations (Scopus)

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model

Affronti, H. C., Long, M. D., Rosario, S. R., Gillard, B. M., Karasik, E., Boerlin, C. S., Pellerite, A. J., Foster, B. A., Attwood, K., Pili, R., Wilton, J. H., Campbell, M. J. & Smiraglia, D. J., Jan 1 2017, In : Oncotarget. 8, 61, p. 103758-103774 17 p.

Research output: Contribution to journalArticle

Folic Acid
Prostatic Neoplasms
Recurrence
Androgens
Heterografts
53 Citations (Scopus)

Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer

Fontana, L., Adelaiye, R. M., Rastelli, A. L., Miles, K. M., Ciamporcero, E., Longo, V. D., Nguyen, H., Vessella, R. & Pili, R., Dec 2013, In : Oncotarget. 4, 12, p. 2451-2461 11 p.

Research output: Contribution to journalArticle

Dietary Proteins
Heterografts
Prostatic Neoplasms
Breast Neoplasms
Diet
3 Citations (Scopus)

Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy

Orillion, A., Damayanti, N. P., Shen, L., Adelaiye-Ogala, R., Affronti, H., Elbanna, M., Chintala, S., Ciesielski, M., Fontana, L., Kao, C., Elzey, B. D., Ratliff, T. L., Nelson, D. E., Smiraglia, D., Abrams, S. I. & Pili, R., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6383-6395 13 p.

Research output: Contribution to journalArticle

Dietary Proteins
Immunotherapy
Macrophages
Neoplasms
Amino Acids
405 Citations (Scopus)

Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth

Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., Dang, C. V., Liu, J. O. & Semenza, G. L., Dec 16 2008, In : Proceedings of the National Academy of Sciences of the United States of America. 105, 50, p. 19579-19586 8 p.

Research output: Contribution to journalArticle

Hypoxia-Inducible Factor 1
Cardiac Glycosides
Digoxin
Growth
Neoplasms
23 Citations (Scopus)

Dll4 blockade potentiates the anti-tumor Effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts

Miles, K. M., Seshadri, M., Ciamporcero, E., Adelaiye, R., Gillard, B., Sotomayor, P., Attwood, K., Shen, L., Conroy, D., Kuhnert, F., Lalani, A. S., Thurston, G. & Pili, R., Nov 13 2014, In : PLoS One. 9, 11, e112371.

Research output: Contribution to journalArticle

vascular endothelial growth factors
kidney cells
Renal Cell Carcinoma
Heterografts
Vascular Endothelial Growth Factor A
20 Citations (Scopus)

Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer

Tolcher, A. W., Chi, K. N., Shore, N. D., Pili, R., Molina, A., Acharya, M., Kheoh, T., Jiao, J. J., Gonzalez, M., Trinh, A., Pankras, C. & Tran, N., Aug 2012, In : Cancer Chemotherapy and Pharmacology. 70, 2, p. 305-313 9 p.

Research output: Contribution to journalArticle

Castration
Prednisone
Prostatic Neoplasms
Electrocardiography
Pharmacokinetics
141 Citations (Scopus)

Endogenous reactivation of the RARβ2 tumor suppressor gene epigenetically silenced in breast cancer

Sirchia, S. M., Ren, M., Pili, R., Sironi, E., Somenzi, G., Ghidoni, R., Toma, S., Nicolò, G. & Sacchi, N., May 1 2002, In : Cancer Research. 62, 9, p. 2455-2461 7 p.

Research output: Contribution to journalArticle

Retinoic Acid Receptors
Tumor Suppressor Genes
Breast Neoplasms
Chromatin
DNA Methylation
18 Citations (Scopus)

Endothelial cell Ca2+ increases upon tumor cell contact and modulates cell-cell adhesion

Pili, R., Corda, S., Passaniti, A., Ziegelstein, R. C., Heldman, A. W. & Capogrossi, M. C., 1993, In : Journal of Clinical Investigation. 92, 6, p. 3017-3022 6 p.

Research output: Contribution to journalArticle

Cell Adhesion
Endothelial Cells
Neoplasms
Melanoma
Ethane

Endothelial cell Ca2+ is increased by melanoma cell adhesion

Pili, R., Ziegelstein, R. C., Passaniti, A. & Capogrossi, M. C., 1993, In : Clinical Chemistry and Enzymology Communications. 6, 1-2, p. 79-83 5 p.

Research output: Contribution to journalArticle

Cell adhesion
Endothelial cells
Cell Adhesion
Melanoma
Endothelial Cells
58 Citations (Scopus)

Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma

Orillion, A., Hashimoto, A., Damayanti, N., Shen, L., Adelaiye-Ogala, R., Arisa, S., Chintala, S., Ordentlich, P., Kao, C., Elzey, B., Gabrilovich, D. & Pili, R., Sep 1 2017, In : Clinical Cancer Research. 23, 17, p. 5187-5201 15 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Tumor Microenvironment
Lung
Immunosuppressive Agents
Neoplasms
67 Citations (Scopus)

Epigenetic modulation of retinoic acid receptor β2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma

Wang, X. F., Qian, D. Z., Ren, M., Kato, Y., Wei, Y., Zhang, L., Fansler, Z., Clark, D., Nakanishi, O. & Pili, R., May 1 2005, In : Clinical Cancer Research. 11, 9, p. 3535-3542 8 p.

Research output: Contribution to journalArticle

Retinoic Acid Receptors
Histone Deacetylase Inhibitors
Renal Cell Carcinoma
Epigenomics
Isotretinoin

Epigenetic targeting and histone deacetylase inhibition in RCC

Ramakrishnan, S. & Pili, R., Nov 1 2012, Renal Cell Carcinoma: Translational Biology, Personalized Medicine, and Novel Therapeutic Targets. Springer US, Vol. 9781461424000. p. 193-211 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Histone Deacetylases
Renal Cell Carcinoma
Epigenomics
Histone Code
Neoplasms

Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))

Ruggeri, B., Singh, J., Gingrich, D., Angeles, T., Albom, M., Yang, S., Chang, H., Robinson, C., Hunter, K., Dobrzanski, P., Jones-Bolin, S., Pritchard, S., Aimone, L., Klein-Szanto, A., Herbert, J. M., Bono, F., Schaeffer, P., Casellas, P., Bourie, B., Pili, R. & 6 others, Isaacs, J., Ator, M., Hudkins, R., Vaught, J., Mallamo, J. & Dionne, C., Nov 1 2003, In : Cancer Research. 63, 21, p. 7543 1 p.

Research output: Contribution to journalComment/debate

Vascular Endothelial Growth Factor Receptor
Protein-Tyrosine Kinases
Research
Neoplasms
N,N-dimethylglycine 3-(5,6,7,13-tetrahydro-9-((1-methylethoxy)methyl)-5-oxo-12H-indeno(2,1-a)pyrrolo(3,4-c)carbazol-12-yl)propyl ester
10 Citations (Scopus)

EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming

Adelaiye-Ogala, R., Budka, J., Damayanti, N. P., Arrington, J., Ferris, M., Hsu, C. C., Chintala, S., Orillion, A., Miles, K. M., Shen, L., Elbanna, M., Ciamporcero, E., Arisa, S., Pettazzoni, P., Draetta, G. F., Seshadri, M., Hancock, B., Radovich, M., Kota, J., Buck, M. & 9 others, Keilhack, H., McCarthy, B. P., Persohn, S. A., Territo, P. R., Zang, Y., Irudayaraj, J., Tao, W. A., Hollenhorst, P. & Pili, R., Dec 1 2017, In : Cancer Research. 77, 23, p. 6651-6666 16 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Receptor Protein-Tyrosine Kinases
Transferases
Drug Resistance
Heterografts
4 Citations (Scopus)

Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer

Ellis, L., Ku, S. Y., Li, Q., Azabdaftari, G., Seliski, J., Olson, B., Netherby, C. S., Tang, D. G., Abrams, S. I., Goodrich, D. W. & Pili, R., Sep 15 2016, In : Prostate. 76, 13, p. 1192-1202 11 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Cell Line
Tumor Microenvironment
Prostate
Transgenic Mice
9 Citations (Scopus)

Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis

Ellis, L., Lehet, K., Ku, S. Y., Azabdaftari, G. & Pili, R., 2014, In : Oncoscience. 1, 10, p. 609-613 5 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Metastasis
Transplants
Lymph
Androgens
16 Citations (Scopus)

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts

Wei, L., Chintala, S., Ciamporcero, E., Ramakrishnan, S., Elbanna, M., Wang, J., Hu, Q., Glenn, S. T., Murakami, M., Liu, L., Gomez, E. C., Sun, Y., Conroy, J., Miles, K. M., Malathi, K., Ramaiah, S., Anbarasu, A., Woloszynska-Read, A., Johnson, C. S., Conroy, J. & 3 others, Liu, S., Morrison, C. D. & Pili, R., 2016, In : Oncotarget. 7, 47, p. 76374-76389 16 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Heterografts
Urinary Bladder Neoplasms
Cisplatin
Mutation
1 Citation (Scopus)

Genomic profiling of collecting duct renal carcinoma

Chintala, S. & Pili, R., 2016, In : Aging. 8, 10, p. 2260-2261 2 p.

Research output: Contribution to journalEditorial

Renal Cell Carcinoma
11 Citations (Scopus)

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma

Ramakrishnan, S., Ku, S. Y., Ciamporcero, E., Miles, K. M., Attwood, K., Chintala, S., Shen, L., Ellis, L., Sotomayor, P., Swetzig, W., Huang, R., Conroy, D., Orillion, A., Das, G. & Pili, R., 2016, In : BMC Cancer. 16, 1, 617.

Research output: Contribution to journalArticle

Histone Deacetylases
Renal Cell Carcinoma
Cell Movement
Protein Isoforms
Cell Line
16 Citations (Scopus)

High-dose interleukin-2 therapy for metastatic renal cell carcinoma: A contemporary experience

Hanzly, M., Aboumohamed, A., Yarlagadda, N., Creighton, T., Digiorgio, L., Fredrick, A., Rao, G., Mehedint, D., George, S., Attwood, K., Kauffman, E., Narashima, D., Khushalani, N. I., Pili, R. & Schwaab, T., 2014, In : Urology. 83, 5, p. 1129-1134 6 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Interleukin-2
Kidney
Therapeutics
Disease-Free Survival
55 Citations (Scopus)

Histone deacetylase inhibitors: Advancing therapeutic strategies in hematological and solid malignancies

Ellis, L. & Pili, R., 2010, In : Pharmaceuticals. 3, 8, p. 2441-2469 29 p.

Research output: Contribution to journalReview article

Histone Deacetylase Inhibitors
Hematologic Neoplasms
Histone Deacetylases
Autophagy
Apoptosis
14 Citations (Scopus)

Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma

Ramakrishnan, S. & Pili, R., Jul 2013, In : Cancer Journal (United States). 19, 4, p. 333-340 8 p.

Research output: Contribution to journalReview article

Histone Deacetylase Inhibitors
Renal Cell Carcinoma
Epigenomics
Histones
Chromatin Assembly and Disassembly
27 Citations (Scopus)

Histone deacetylase inhibitors as immunomodulators in cancer therapeutics

Shen, L., Orillion, A. & Pili, R., Mar 1 2016, In : Epigenomics. 8, 3, p. 415-428 14 p.

Research output: Contribution to journalReview article

Histone Deacetylase Inhibitors
Immunologic Factors
Neoplasms
Therapeutics
Cytostatic Agents
11 Citations (Scopus)

Histone modifications: Implications in renal cell carcinoma

Ramakrishnan, S., Ellis, L. & Pili, R., Aug 2013, In : Epigenomics. 5, 4, p. 453-462 10 p.

Research output: Contribution to journalArticle

Histone Code
Renal Cell Carcinoma
Kidney Pelvis
Epigenomics
Genes
155 Citations (Scopus)

Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1

Volpert, O. V., Pili, R., Sikder, H. A., Nelius, T., Zaichuk, T., Morris, C., Shiflett, C. B., Devlin, M. K., Conant, K. & Alani, R. M., Dec 2002, In : Cancer Cell. 2, 6, p. 473-483 11 p.

Research output: Contribution to journalArticle

Thrombospondin 1
Embryonic Structures
Fibroblasts
Angiogenesis Inhibitors
Neutralizing Antibodies
72 Citations (Scopus)

Identification of ABR-215050 as lead second generation quinoline-3- carboxamide anti-angiogenic agent for the treatment of prostate cancer

Isaacs, J. T., Pili, R., Qian, D. Z., Dalrymple, S. L., Garrison, J. B., Kyprianou, N., Björk, A., Olsson, A. & Leanderson, T., Dec 1 2006, In : Prostate. 66, 16, p. 1768-1778 11 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Growth
Multiple Sclerosis
Neoplasms
Clinical Trials
77 Citations (Scopus)

Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target

Chong, C. R., Qian, D. Z., Pan, F., Wei, Y., Pili, R., Sullivan, D. J. & Liu, J. O., May 4 2006, In : Journal of Medicinal Chemistry. 49, 9, p. 2677-2680 4 p.

Research output: Contribution to journalArticle

Inosine Monophosphate
Endothelial cells
Oxidoreductases
Endothelial Cells
Cell proliferation
14 Citations (Scopus)

Immune parameters in a populatio of institutionalized elderly subjects: influence of depressive disorders and endocrinological correlations

Bartoloni, C., Guidi, L., Frasca, D., Antico, L., Pili, R., Cursi, F., Di Giovanni, A., Rumi, C., Menini, E., Carbonin, P., Doria, G. & Gambassi, G., 1991, In : Mechanisms of Ageing and Development. 60, 1, p. 1-12 12 p.

Research output: Contribution to journalArticle

Lymphocytes
Depressive Disorder
Hydrocortisone
Endorphins
Adrenocorticotropic Hormone
19 Citations (Scopus)

Immunomodulation by entinostat in renal cell carcinoma patients receiving high-dose interleukin 2: A multicenter, single-arm, phase I/II trial (NCI-CTEP#7870)

Pili, R., Quinn, D. I., Hammers, H. J., Monk, P., George, S., Dorff, T. B., Olencki, T., Shen, L., Orillion, A., Lamonica, D., Fragomeni, R. S., Szabo, Z., Hutson, A., Groman, A., Perkins, S., Piekarz, R. & Carducci, M. A., Dec 1 2017, In : Clinical Cancer Research. 23, 23, p. 7199-7208 10 p.

Research output: Contribution to journalArticle

Immunomodulation
Renal Cell Carcinoma
Interleukin-2
Confidence Intervals
Disease-Free Survival
15 Citations (Scopus)

Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: Are surgical complications or disease related factors responsible?

O'Malley, R. L., Brewer, K. A., Hayn, M. H., Kim, H. L., Underwood, W., Pili, R. & Schwaab, T., Sep 2011, In : Urology. 78, 3, p. 595-600 6 p.

Research output: Contribution to journalArticle

Nephrectomy
Survival
Renal Cell Carcinoma
Therapeutics
Intraoperative Complications
36 Citations (Scopus)

Impairment of lymphocyte activities in depressed aged subjects

Guidi, L., Bartoloni, C., Frasca, D., Antico, L., Pili, R., Cursi, F., Tempesta, E., Rumi, C., Menini, E., Carbonin, P., Doria, G. & Gambassi, G., 1991, In : Mechanisms of Ageing and Development. 60, 1, p. 13-24 12 p.

Research output: Contribution to journalArticle

Lymphocytes
Interleukin-2
Depression
Psychology
Depressive Disorder
35 Citations (Scopus)

Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells

Pettazzoni, P., Pizzimenti, S., Toaldo, C., Sotomayor, P., Tagliavacca, L., Liu, S., Wang, D., Minelli, R., Ellis, L., Atadja, P., Ciamporcero, E., Dianzani, M. U., Barrera, G. & Pili, R., Jan 15 2011, In : Free Radical Biology and Medicine. 50, 2, p. 313-322 10 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Cell Cycle Checkpoints
Lipid Peroxidation
DNA Damage
Prostatic Neoplasms
7 Citations (Scopus)

Inhibition of Hsp90 augments docetaxel therapy in castrate resistant prostate cancer

Ku, S. Y., Lasorsa, E., Adelaiye, R., Ramakrishnan, S., Ellis, L. & Pili, R., Jul 29 2014, In : PLoS One. 9, 7, e103680.

Research output: Contribution to journalArticle

docetaxel
HSP90 Heat-Shock Proteins
Androgen Receptors
prostatic neoplasms
Prostatic Neoplasms
40 Citations (Scopus)

Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store

Ziegelstein, R. C., Corda, S., Pili, R., Passaniti, A., Lefer, D., Zweier, J. L., Fraticelli, A. & Capogrossi, M. C., Oct 1994, In : Circulation. 90, 4 I, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

Monocytes
Neutrophils
Leukocytes
Endothelial Cells
Calcium
29 Citations (Scopus)

Intravenous Bevacizumab Causes Regression of Choroidal Neovascularization Secondary to Diseases Other Than Age-related Macular Degeneration

Nguyen, Q. D., Shah, S. M., Hafiz, G., Do, D. V., Haller, J. A., Pili, R., Zimmer-Galler, I. E., Janjua, K., Symons, R. C. A. & Campochiaro, P. A., Feb 2008, In : American Journal of Ophthalmology. 145, 2

Research output: Contribution to journalArticle

Choroidal Neovascularization
Macular Degeneration
Fluorescein
Diabetic Retinopathy
Intravenous Infusions
66 Citations (Scopus)

In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor

Mühlhauser, J., Pili, R., Merrill, M. J., Maeda, H., Passaniti, A., Crystal, R. G. & Capogrossi, M. C., Nov 1995, In : Human Gene Therapy. 6, 11, p. 1457-1465 9 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factor 1
Adenoviridae
Galactosidases
Angiogenesis Inducing Agents
Human Umbilical Vein Endothelial Cells
34 Citations (Scopus)

In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells

Qian, D. Z., Ren, M., Wei, Y., Wang, X., Van De Geijn, F., Rasmussen, C., Nakanishi, O., Sacchi, N. & Pili, R., Jun 15 2005, In : Prostate. 64, 1, p. 20-28 9 p.

Research output: Contribution to journalArticle

Retinoic Acid Receptors
Histone Deacetylase Inhibitors
Retinoids
Transcriptional Activation
Prostatic Neoplasms
20 Citations (Scopus)

Is HIF-1α a valid therapeutic target?

Pili, R. & Donehower, R. C., Apr 2 2003, In : Journal of the National Cancer Institute. 95, 7, p. 498-499 2 p.

Research output: Contribution to journalEditorial

Alpha Subunit Hypoxia-Inducible Factor 1
Vascular Endothelial Growth Factors
Indazoles
Endothelial Growth Factors
Pathologic Neovascularization

Is this a true renaissance for the treatment of prostate cancer?

Pili, R., Dec 2010, In : Oncology. 24, 14

Research output: Contribution to journalComment/debate

Prostatic Neoplasms
Renaissance

Is this a true renaissance for the treatment of prostate cancer?

Pili, R., Dec 2010, In : Oncology (Williston Park, N.Y.). 24, 14, p. 1327-1328 2 p.

Research output: Contribution to journalComment/debate

Androgen Antagonists
Tissue Extracts
Antineoplastic Agents
Prostatic Neoplasms
Renaissance
144 Citations (Scopus)

Kidney cancer

Motzer, R. J., Agarwal, N., Beard, C., Bolger, G. B., Boston, B., Carducci, M. A., Choueiri, T. K., Figlin, R. A., Fishman, M., Hancock, S. L., Hudes, G. R., Jonasch, E., Kessinger, A., Kuzel, T. M., Lange, P. H., Levine, E. G., Margolin, K. A., Michaelson, M. D., Olencki, T., Pili, R. & 5 others, Redman, B. G., Robertson, C. N., Schwartz, L. H., Sheinfeld, J. & Wang, J., Jun 2009, In : JNCCN Journal of the National Comprehensive Cancer Network. 7, 6, p. 618-630 13 p.

Research output: Contribution to journalReview article

Kidney Neoplasms
Renal Cell Carcinoma
Cell- and Tissue-Based Therapy
Protein-Tyrosine Kinases
Interferons
64 Citations (Scopus)

Kidney cancer

Motzer, R. J., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Carducci, M. A., Chang, S. S., Choueiri, T. K., Hancock, S. L., Hudes, G. R., Jonasch, E., Josephson, D., Kuzel, T. M., Levine, E. G., Lin, D. W., Margolin, K. A., Michaelson, M. D., Olencki, T., Pili, R., Ratliff, T. W. & 7 others, Redman, B. G., Robertson, C. N., Ryan, C. J., Sheinfeld, J., Spiess, P. E., Wang, J. & Wilder, R. B., Sep 1 2011, In : JNCCN Journal of the National Comprehensive Cancer Network. 9, 9, p. 960-977 18 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Kidney cancer: Clinical practice guidelines

Motzer, R. J., Carducci, M. A., Fishman, M., Hancock, S. L., Hauke, R. J., Hudes, G. R., Kantoff, P., Kuzel, T. M., Lange, P. H., Levine, E. G., Logothetis, C., Margolin, K. A., Pili, R., Pohar, K. S., Redman, B. G., Richey, S., Robertson, C. N., Samlowski, W. E., Sheinfeld, J. & Urban, D. A., Jan 2005, In : JNCCN Journal of the National Comprehensive Cancer Network. 3, 1, p. 84-93 10 p.

Research output: Contribution to journalReview article

Kidney Neoplasms
Practice Guidelines
Nephrectomy
Renal Cell Carcinoma
Neoplasms
44 Citations (Scopus)

Kidney cancer, version 2.2014

Motzer, R. J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Chang, S. S., Choueiri, T. K., Derweesh, I. H., Gupta, S., Hancock, S. L., Kim, J. J., Kuzel, T. M., Lam, E. T., Lau, C., Levine, E. G., Lin, D. W., Margolin, K. A., Michaelson, M. D., Olencki, T. & 12 others, Pili, R., Plimack, E. R., Rampersaud, E. N., Redman, B. G., Ryan, C. J., Sheinfeld, J., Sircar, K., Somer, B., Wang, J., Wilder, R. B., Dwyer, M. A. & Kumar, R., Feb 1 2014, In : JNCCN Journal of the National Comprehensive Cancer Network. 12, 2, p. 175-182 8 p.

Research output: Contribution to journalReview article

Kidney Neoplasms
Practice Guidelines
Guidelines
Carcinoma
Therapeutics
153 Citations (Scopus)

Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines

Motzer, R. J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Gupta, S., Hancock, S. L., Kim, J. J., Kuzel, T. M., Lam, E. T., Lau, C., Levine, E. G., Lin, D. W., Michaelson, M. D., Olencki, T. & 12 others, Pili, R., Plimack, E. R., Rampersaud, E. N., Redman, B. G., Ryan, C. J., Sheinfeld, J., Shuch, B., Sircar, K., Somer, B., Wilder, R. B., Dwyer, M. & Kumar, R., Feb 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 2, p. 151-159 9 p.

Research output: Contribution to journalReview article

Kidney Neoplasms
Renal Cell Carcinoma
Guidelines
Protein-Tyrosine Kinases
Therapeutics